A Case Report with Severe Thrombocytopenia Induced by Axitinib

Axitinib is an oral, second-generation tyrosine kinase inhibitor that is selective for vascular endothelial growth factor receptors (VEGFR). This agent is approved as monotherapy or in combination with immune checkpoint inhibitors for the treatment of metastatic renal cell carcinoma. Axitinib is ass...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Case Rep Hematol
Hlavní autoři: Koksal, Ulkuhan I., Goffin, Janeiro Valle, Lewis, Brian, Sartor, Oliver A., Belyaeva, Elizaveta, Socola, Francisco, Barata, Pedro C.
Médium: Artigo
Jazyk:Inglês
Vydáno: Hindawi 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029294/
https://ncbi.nlm.nih.gov/pubmed/32089908
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2020/7520783
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky